- Home
- SNTI vs FAT Comparison
SNTI vs FAT Comparison
Compare SNTI & FAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- FAT
- Stock Information
- Founded
- SNTI 2016
- FAT 2017
- Country
- SNTI United States
- FAT United States
- Employees
- SNTI N/A
- FAT N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- FAT Restaurants
- Sector
- SNTI Health Care
- FAT Consumer Discretionary
- Exchange
- SNTI Nasdaq
- FAT Nasdaq
- Market Cap
- SNTI 39.6M
- FAT 44.0M
- IPO Year
- SNTI N/A
- FAT 2017
- Fundamental
- Price
- SNTI $1.56
- FAT $1.81
- Analyst Decision
- SNTI Strong Buy
- FAT Strong Buy
- Analyst Count
- SNTI 2
- FAT 1
- Target Price
- SNTI $8.50
- FAT $10.00
- AVG Volume (30 Days)
- SNTI 107.2K
- FAT 67.2K
- Earning Date
- SNTI 08-07-2025
- FAT 07-30-2025
- Dividend Yield
- SNTI N/A
- FAT 7.61%
- EPS Growth
- SNTI N/A
- FAT N/A
- EPS
- SNTI N/A
- FAT N/A
- Revenue
- SNTI N/A
- FAT $577,500,000.00
- Revenue This Year
- SNTI N/A
- FAT N/A
- Revenue Next Year
- SNTI $150.00
- FAT $8.68
- P/E Ratio
- SNTI N/A
- FAT N/A
- Revenue Growth
- SNTI N/A
- FAT 0.96
- 52 Week Low
- SNTI $1.46
- FAT $1.75
- 52 Week High
- SNTI $16.94
- FAT $4.10
- Technical
- Relative Strength Index (RSI)
- SNTI 37.24
- FAT 31.21
- Support Level
- SNTI $1.52
- FAT $1.75
- Resistance Level
- SNTI $1.65
- FAT $1.97
- Average True Range (ATR)
- SNTI 0.10
- FAT 0.11
- MACD
- SNTI 0.03
- FAT -0.01
- Stochastic Oscillator
- SNTI 50.00
- FAT 13.89
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About FAT FAT Brands Inc.
FAT Brands Inc is a multi-brand restaurant franchising company. It develops, markets, acquires, and manages quick service, fast casual, casual dining, and polished casual dining restaurant concepts around the world. The company operates as a franchisor of restaurants, where the company generally does not own or operate the restaurant locations but rather generates revenue by charging franchisees an initial franchise fee as well as ongoing royalties. For some of the company's brands, it also directly owns and operates restaurant locations. Its brands include Round Table Pizza, Fatburger, Johnny Rockets, Twin Peaks, and Elevation Burger among others. Geographically, the majority of the revenue for the company is generated from the United States.